92 related articles for article (PubMed ID: 16109604)
21. Variations in the low levels of cyclin D1/BCL1 have prognostic value in chronic lymphocytic leukemia.
Ravandi-Kashani F; O'Brien S; Manshouri T; Lerner S; Sim S; Dodd K; Kantarjian H; Freireich E; Keating M; Albitar M
Leuk Res; 2000 Jun; 24(6):469-74. PubMed ID: 10781679
[TBL] [Abstract][Full Text] [Related]
22. High intracellular content of cyclin-dependent kinase inhibitor p27(Kip1) in early- and intermediate stage B-cell chronic lymphocytic leukemia lymphocytes predicts rapid progression of the disease.
Wolowiec D; Wojtowicz M; Ciszak L; Kosmaczewska A; Frydecka I; Potoczek S; Urbaniak-Kujda D; Kapelko-Slowik K; Kuliczkowski K
Eur J Haematol; 2009 Apr; 82(4):260-6. PubMed ID: 19187271
[TBL] [Abstract][Full Text] [Related]
23. Role of myeloid cell factor-1 (Mcl-1) in chronic lymphocytic leukemia.
Johnston JB; Paul JT; Neufeld NJ; Haney N; Kropp DM; Hu X; Cheang M; Gibson SB
Leuk Lymphoma; 2004 Oct; 45(10):2017-27. PubMed ID: 15370246
[TBL] [Abstract][Full Text] [Related]
24. Selective usage of D-Type cyclins by Ewing's tumors and rhabdomyosarcomas.
Zhang J; Hu S; Schofield DE; Sorensen PH; Triche TJ
Cancer Res; 2004 Sep; 64(17):6026-34. PubMed ID: 15342383
[TBL] [Abstract][Full Text] [Related]
25. Retinoid targeting of different D-type cyclins through distinct chemopreventive mechanisms.
Ma Y; Feng Q; Sekula D; Diehl JA; Freemantle SJ; Dmitrovsky E
Cancer Res; 2005 Jul; 65(14):6476-83. PubMed ID: 16024653
[TBL] [Abstract][Full Text] [Related]
26. Protein Expression for Novel Prognostic Markers (Cyclins D1, D2, D3, B1, B2, ITGβ7, FGFR3, PAX5) Correlate With Previously Reported Gene Expression Profile Patterns in Plasma Cell Myeloma.
Mansoor A; Akhter A; Pournazari P; Mahe E; Shariff S; Farooq F; Elyamany G; Shahbani-Rad MT; Rashid-Kolvear F
Appl Immunohistochem Mol Morphol; 2015; 23(5):327-33. PubMed ID: 25265432
[TBL] [Abstract][Full Text] [Related]
27. D-type cyclins in adult human testis and testicular cancer: relation to cell type, proliferation, differentiation, and malignancy.
Bartkova J; Rajpert-de Meyts E; Skakkebaek NE; Bartek J
J Pathol; 1999 Apr; 187(5):573-81. PubMed ID: 10398124
[TBL] [Abstract][Full Text] [Related]
28. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
29. Cyclin D1 and D3 associate with the SCF complex and are coordinately elevated in breast cancer.
Russell A; Thompson MA; Hendley J; Trute L; Armes J; Germain D
Oncogene; 1999 Mar; 18(11):1983-91. PubMed ID: 10208420
[TBL] [Abstract][Full Text] [Related]
30. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
Said TK; Medina D
Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257
[TBL] [Abstract][Full Text] [Related]
31. Expression of D-type cyclins in colon cancer and in cell lines from colon carcinomas.
Mermelshtein A; Gerson A; Walfisch S; Delgado B; Shechter-Maor G; Delgado J; Fich A; Gheber L
Br J Cancer; 2005 Aug; 93(3):338-45. PubMed ID: 16012517
[TBL] [Abstract][Full Text] [Related]
32. CTLA-4 affects expression of key cell cycle regulators of G0/G1 phase in neoplastic lymphocytes from patients with chronic lymphocytic leukaemia.
Ciszak L; Frydecka I; Wolowiec D; Szteblich A; Kosmaczewska A
Clin Exp Med; 2016 Aug; 16(3):317-32. PubMed ID: 26003188
[TBL] [Abstract][Full Text] [Related]
33. D-type cyclins in superficial and muscle-invasive bladder urothelial carcinoma: correlation with clinicopathological data and prognostic significance.
Levidou G; Saetta AA; Karlou M; Thymara I; Pratsinis H; Pavlopoulos P; Isaiadis D; Diamantopoulou K; Patsouris E; Korkolopoulou P
J Cancer Res Clin Oncol; 2010 Oct; 136(10):1563-71. PubMed ID: 20174823
[TBL] [Abstract][Full Text] [Related]
34. Estrogen-induced cyclin D1 and D3 gene expressions during mouse uterine cell proliferation in vivo: differential induction mechanism of cyclin D1 and D3.
Geum D; Sun W; Paik SK; Lee CC; Kim K
Mol Reprod Dev; 1997 Apr; 46(4):450-8. PubMed ID: 9094091
[TBL] [Abstract][Full Text] [Related]
35. The Expression of Toll-Like Receptors in Patients with B-Cell Chronic Lymphocytic Leukemia.
Rybka J; Butrym A; Wróbel T; Jaźwiec B; Bogucka-Fedorczuk A; Poręba R; Kuliczkowski K
Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):147-150. PubMed ID: 28083607
[TBL] [Abstract][Full Text] [Related]
36. Fludarabine-induced apoptosis of B chronic lymphocytic leukemia cells includes early cleavage of p27kip1 by caspases.
Sanhes L; Tang R; Delmer A; DeCaprio JA; Ajchenbaum-Cymbalista F
Leukemia; 2003 Jun; 17(6):1104-11. PubMed ID: 12764376
[TBL] [Abstract][Full Text] [Related]
37. CD126 and Targeted Therapy with Tocilizumab in Chronic Lymphocytic Leukemia.
Liu FT; Jia L; Wang P; Farren T; Li H; Hao X; Agrawal SG
Clin Cancer Res; 2016 May; 22(10):2462-9. PubMed ID: 26712690
[TBL] [Abstract][Full Text] [Related]
38. Expression of cyclins A, D2 and D3 in individual normal mitogen stimulated lymphocytes and in MOLT-4 leukemic cells analyzed by multiparameter flow cytometry.
Gong J; Bhatia U; Traganos F; Darzynkiewicz Z
Leukemia; 1995 May; 9(5):893-9. PubMed ID: 7769853
[TBL] [Abstract][Full Text] [Related]
39. Critical role for D-type cyclins in cellular transformation induced by E6/E7 of human papillomavirus type 16 and E6/E7/ErbB-2 cooperation.
Yasmeen A; Hosein AN; Yu Q; Al Moustafa AE
Cancer Sci; 2007 Jul; 98(7):973-7. PubMed ID: 17489986
[TBL] [Abstract][Full Text] [Related]
40. Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression.
Molica S; Vitelli G; Mirabelli R; Digiesu G; Giannarelli D; Cuneo A; Ribatti D; Vacca A
Eur J Haematol; 2006 Jan; 76(1):51-7. PubMed ID: 16343271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
